▲GC Green Cross MS dengue virus diagnostic kit (antibody)
GC Green Cross MS (CEO Sakong Young-hee) announced on the 18th that it has obtained permission from the Ministry of Food and Drug Safety to export the dengue virus rapid diagnostic kit ‘GENEDIA W Dengue NS1 Ag’ antigen test and ‘GENEDIA W Dengue IgM/IgG Ab’ antibody test. Yes.
According to the company, the dengue fever diagnostic kit developed this time uses a similar principle to the COVID-19 rapid diagnostic kit familiar to consumers, and can diagnose dengue fever within 20 minutes through a blood sample. In particular, it is characterized by being able to diagnose all four dengue virus serotypes, and internally secured clinical specimen tests confirmed higher sensitivity and accuracy compared to other companies.
A company official said, “The number of infected people around the world is rapidly increasing due to the recent spread of the dengue virus, a mosquito-borne disease, mainly in Southeast Asia and South America. We are expecting a rapid increase in sales in the mosquito-borne infection virus diagnostic kit market by obtaining this export license.” He said, “Follow-up product development for mosquito-borne infectious diseases other than dengue fever is in progress.”
Copyright © Pax Economy TV Unauthorized reproduction and redistribution prohibited
2023-09-18 13:21:55
#Green #Cross #obtains #permission #export #dengue #virus #rapid #diagnostic #kit…Overseas #sales #expand #earnest
